NOTRELOAD AI
  • NOTRELOAD AI
  • Stocks BUZZ.
  • #TrumpTrade
  • 24-HOUR Pass →
  • Invest ↗
Sign in Subscribe

JPMorgan Upgrades Citi: Positive Outlook for 2026

JPMorgan upgrades Citi to Overweight, citing strong economy, markets, and improved profitability. Price target raised to $124.

JPMorgan Upgrades Citi: Positive Outlook for 2026
Credit: Bloomberg
Already have an account? Sign in.
Featured/ 12/12/2025 · 8:19 AM
C
/ Read more

Feed↓

ImmunityBio Shares Jump on European Bladder Cancer Treatment Recommendation
12/12/2025 · 10:30 AM

ImmunityBio Shares Jump on European Bladder Cancer Treatment Recommendation

ImmunityBio stock climbed 8.5% after European regulators recommended approval for Anktiva, a bladder cancer treatment that helped over 70% of patients in clinical trials.

/ Subscriber only
Guggenheim Upgrades Bristol Myers to Buy with $62 Target
12/12/2025 · 9:52 AM

Guggenheim Upgrades Bristol Myers to Buy with $62 Target

Guggenheim raises Bristol Myers to Buy, citing low expectations, strong pipeline, and potential entry point for value-focused investors.

/ Subscriber only
Arcus and Gilead Halt Cancer Trial After Treatment Fails to Extend Patient Survival
Featured/ 12/12/2025 · 9:31 AM

Arcus and Gilead Halt Cancer Trial After Treatment Fails to Extend Patient Survival

Arcus Biosciences discontinues Phase 3 STAR-221 cancer trial after independent review finds experimental treatment unlikely to improve survival for gastric and esophageal cancer patients.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe